We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Co. Investors Seek OK For Early $3.8M Settlement

Law360, New York (April 17, 2017, 2:55 PM EDT) -- A putative class of investors in Amicus Therapeutics Inc. who said the company’s misleading statements about their interaction with the U.S. Food and Drug Administration amounted to securities fraud asked a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New Jersey

Nature of Suit

850(Securities/Commodities)

Judge

Subscribers Only

Date Filed

October 7, 2015

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.